Bjørn Braathen1, Theis Tønnessen. 1. Department of Cardiothoracic Surgery, Ullevål University Hospital, University of Oslo, and Center for Heart Failure Research, Oslo, Norway.
Abstract
OBJECTIVES: Cardiac arrest during cardiac surgery is most commonly induced by cold blood or cold crystalloid cardioplegia. The results from clinical studies are divergent regarding which of the 2 solutions provides better myocardial protection. This might be explained by several factors. Both heterogeneity in disease for the included patients and the fact that most studies are retrospective in design and that patients with coronary artery disease with different degrees of myocardial ischemia are included might explain these findings. To circumvent these potentially confounding factors, we included in a prospective randomized study only patients undergoing aortic valve replacement for aortic stenosis without other significant cardiac disease. Patients were randomized to antegrade cold crystalloid or cold blood cardioplegia. METHODS:Eighty patients with aortic stenosis undergoing aortic valve replacement without significant coronary artery stenosis or other significant concomitant heart valve disease were included in the study. They were randomized to either antegrade cold blood or cold crystalloid cardioplegic solution delivered through the coronary ostia every 20 minutes throughout the period of aortic crossclamping. Maximum postoperative creatine kinase isoenzymeMB and troponin-T levels, well-established markers of myocardial damage, were compared between the 2 groups. RESULTS: Both maximum postoperative creatine kinase isoenzymeMB and troponin-T levels were significantly higher by approximately 100% in the cohort of patients receiving crystalloid compared with blood cardioplegia. Only in the group of patients receiving cold crystalloid cardioplegia was there a positive correlation between cardiac enzyme levels and crossclamp time. CONCLUSION:Antegrade cold blood cardioplegia provides better myocardial protection than cold crystalloid cardioplegia in patients undergoing aortic valve replacement. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
RCT Entities:
OBJECTIVES:Cardiac arrest during cardiac surgery is most commonly induced by cold blood or cold crystalloid cardioplegia. The results from clinical studies are divergent regarding which of the 2 solutions provides better myocardial protection. This might be explained by several factors. Both heterogeneity in disease for the included patients and the fact that most studies are retrospective in design and that patients with coronary artery disease with different degrees of myocardial ischemia are included might explain these findings. To circumvent these potentially confounding factors, we included in a prospective randomized study only patients undergoing aortic valve replacement for aortic stenosis without other significant cardiac disease. Patients were randomized to antegrade cold crystalloid or cold blood cardioplegia. METHODS: Eighty patients with aortic stenosis undergoing aortic valve replacement without significant coronary artery stenosis or other significant concomitant heart valve disease were included in the study. They were randomized to either antegrade cold blood or cold crystalloid cardioplegic solution delivered through the coronary ostia every 20 minutes throughout the period of aortic crossclamping. Maximum postoperative creatine kinase isoenzyme MB and troponin-T levels, well-established markers of myocardial damage, were compared between the 2 groups. RESULTS: Both maximum postoperative creatine kinase isoenzyme MB and troponin-T levels were significantly higher by approximately 100% in the cohort of patients receiving crystalloid compared with blood cardioplegia. Only in the group of patients receiving cold crystalloid cardioplegia was there a positive correlation between cardiac enzyme levels and crossclamp time. CONCLUSION: Antegrade cold blood cardioplegia provides better myocardial protection than cold crystalloid cardioplegia in patients undergoing aortic valve replacement. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Authors: Paolo Nardi; Sara R Vacirca; Marco Russo; Dionisio F Colella; Carlo Bassano; Antonio Scafuri; Antonio Pellegrino; Gerry Melino; Giovanni Ruvolo Journal: J Thorac Dis Date: 2018-03 Impact factor: 2.895
Authors: Daniel A Lerman; Matilde Otero-Losada; Kiddy Ume; Pablo A Salgado; Sai Prasad; Kelvin Lim; Bruno Péault; Nasri Alotti Journal: J Cardiovasc Surg (Torino) Date: 2017-05-26 Impact factor: 1.888
Authors: Katrine B Buggeskov; Raluca G Maltesen; Bodil S Rasmussen; Munsoor A Hanifa; Morten A V Lund; Reinhard Wimmer; Hanne B Ravn Journal: J Clin Med Date: 2018-11-21 Impact factor: 4.241
Authors: Chee-Hoon Lee; Min Ho Ju; Joon Bum Kim; Cheol Hyun Chung; Sung Ho Jung; Suk Jung Choo; Jae Won Lee Journal: Korean J Thorac Cardiovasc Surg Date: 2014-06-05